Skip to content

Book value per share at other companies

Eli Lilly logo
Eli LillyLLY
$34.82+98.9%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$3.94+27.4%
Opko Health logo
Opko HealthOPK
$1.59-18.7%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$6.26+6.2%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
-$1.35-122%
Erasca, Inc. logo
Erasca, Inc.ERAS
$1.29-8.3%

Other financials

Income statement

See full
Operating income-$58.0M-66.3%
Net income-$53.1M-74.7%
EPS (diluted)-$0.52-44.4%

Balance sheet

See full
Cash & equivalents$52.5M+3.8%
Total debt$956.0K-16.7%
Total equity$480.5M+25.3%
Total assets$530.6M+29.5%

Cash flow

See full
Operating cash flow-$46.0M-4.6%
CapEx-
Free cash flow-$34.5M-27.8%

Valuation

See full
Market cap$973.05M+244%
Enterprise value$921.46M+295%

Returns & leverage

See full
Return on equity-42.9%+1.3pp
Debt / equity0.0×
Current ratio10.9×-4.3×

Where this comes from

Calculated from Olema Pharmaceuticals, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Olema Pharmaceuticals, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Olema Pharmaceuticals, Inc.'s book value per share?
Olema Pharmaceuticals, Inc. (OLMA) reported book value per share of $4.67 in Q1 2026.
How has Olema Pharmaceuticals, Inc.'s book value per share changed year-over-year?
Olema Pharmaceuticals, Inc.'s book value per share increased by 4.1% year-over-year, from $4.49 to $4.67.
What is the long-term trend for Olema Pharmaceuticals, Inc.'s book value per share?
Over 5 years (2020 to 2025), Olema Pharmaceuticals, Inc.'s book value per share has grown at a -35.2% compound annual growth rate (CAGR), from $48.16 to $5.50.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.